Avage Topical and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Avage Topical and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tazarotene topical
Brand name: Avage, Fabior, Tazorac
Synonyms: Avage
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Avage Topical-Lithium ER
- Avage Topical-Lithium Oral Solution
- Avage Topical-Lithium Salts
- Avage Topical-Lithium Syrup and Oral Solution
- Avage Topical-Lithobid
- Avage Topical-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Avalide
- Lithium Controlled-Release and Extended-Release Tablets-Avanafil
- Lithium Controlled-Release and Extended-Release Tablets-Avandamet
- Lithium Controlled-Release and Extended-Release Tablets-Avandaryl
- Lithium Controlled-Release and Extended-Release Tablets-Avandia
- Lithium Controlled-Release and Extended-Release Tablets-Avapro